NCT07174310 A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease Status RECRUITING Phase PHASE3
NCT07055087 Prevent Cognitive Decline in GBA-associated Parkinson's Disease Status NOT_YET_RECRUITING Phase PHASE2
NCT04777331 A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's Disease Status ACTIVE_NOT_RECRUITING Phase PHASE2